These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16504832)

  • 1. Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: the doxycycline trial.
    Brandt KD; Mazzuca SA
    Rheum Dis Clin North Am; 2006 Feb; 32(1):217-34, xi-xii. PubMed ID: 16504832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary TIINE concentrations in a randomized controlled trial of doxycycline in knee osteoarthritis: implications of the lack of association between TIINE levels and joint space narrowing.
    Otterness IG; Brandt KD; Le Graverand MP; Mazzuca SA
    Arthritis Rheum; 2007 Nov; 56(11):3644-9. PubMed ID: 17968918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial.
    Brandt KD; Mazzuca SA; Katz BP; Lane KA; Buckwalter KA; Yocum DE; Wolfe F; Schnitzer TJ; Moreland LW; Manzi S; Bradley JD; Sharma L; Oddis CV; Hugenberg ST; Heck LW
    Arthritis Rheum; 2005 Jul; 52(7):2015-25. PubMed ID: 15986343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug.
    Mazzuca SA; Brandt KD; Katz BP; Lane KA; Bradley JD; Heck LW; Hugenberg ST; Manzi S; Moreland LW; Oddis CV; Schnitzer TJ; Sharma L; Wolfe F; Yocum DE
    Arthritis Rheum; 2004 Dec; 51(6):933-40. PubMed ID: 15593174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of doxycycline on reducing symptoms in knee osteoarthritis: results from a triple-blinded randomised controlled trial.
    Snijders GF; van den Ende CH; van Riel PL; van den Hoogen FH; den Broeder AA;
    Ann Rheum Dis; 2011 Jul; 70(7):1191-6. PubMed ID: 21551510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plain radiography as an outcome measure in clinical trials involving patients with knee osteoarthritis.
    Mazzuca SA; Brandt KD
    Rheum Dis Clin North Am; 1999 May; 25(2):467-80, ix. PubMed ID: 10356429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis.
    Hellio Le Graverand MP; Brandt KD; Mazzuca SA; Katz BP; Buck R; Lane KA; Pickering E; Nemirovskiy OV; Sunyer T; Welsch DJ
    Osteoarthritis Cartilage; 2006 Nov; 14(11):1189-95. PubMed ID: 16753310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of joint pain and Kellgren-Lawrence grade at baseline are better predictors of joint space narrowing than bone scintigraphy in obese women with knee osteoarthritis.
    Mazzuca SA; Brandt KD; Schauwecker DS; Katz BP; Meyer JM; Lane KA; Bradley JD; Hugenberg ST; Wolfe F; Moreland LW; Heck LW; Yocum DE; Schnitzer TJ; Sharma L; Manzi S; Oddis CV
    J Rheumatol; 2005 Aug; 32(8):1540-6. PubMed ID: 16078332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The randomized clinical trial of doxycycline in knee osteoarthritis: comment on the editorial by Dieppe.
    Brandt KD; Mazzuca SA
    Arthritis Rheum; 2006 Feb; 54(2):684. PubMed ID: 16447250
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of joint space narrowing with conventional standing antero-posterior radiographs: relief in mild-to-moderate pain is not a confounder in recent osteoarthritis structure-modifying drug trials.
    Rovati LC; Pavelka K; Giacovelli G; Reginster JY
    Osteoarthritis Cartilage; 2006; 14 Suppl A():A14-8. PubMed ID: 16678450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
    Bingham CO; Buckland-Wright JC; Garnero P; Cohen SB; Dougados M; Adami S; Clauw DJ; Spector TD; Pelletier JP; Raynauld JP; Strand V; Simon LS; Meyer JM; Cline GA; Beary JF
    Arthritis Rheum; 2006 Nov; 54(11):3494-507. PubMed ID: 17075851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind, randomized, placebo controlled study to evaluate the efficacy of erythromycin in patients with knee effusion due to osteoarthritis.
    Sadreddini S; Noshad H; Molaeefard M; Moloudi R; Ardalan MR; Ghojazadeh M
    Int J Rheum Dis; 2009 Apr; 12(1):44-51. PubMed ID: 20374316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo.
    Uebelhart D; Malaise M; Marcolongo R; de Vathaire F; Piperno M; Mailleux E; Fioravanti A; Matoso L; Vignon E
    Osteoarthritis Cartilage; 2004 Apr; 12(4):269-76. PubMed ID: 15023378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis.
    Lohmander LS; Brandt KD; Mazzuca SA; Katz BP; Larsson S; Struglics A; Lane KA
    Arthritis Rheum; 2005 Oct; 52(10):3160-7. PubMed ID: 16200596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why should we expect a structure-modifying osteoarthritis drug to relieve osteoarthritis pain?
    Brandt KD
    Ann Rheum Dis; 2011 Jul; 70(7):1175-7. PubMed ID: 21622770
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial.
    Raynauld JP; Buckland-Wright C; Ward R; Choquette D; Haraoui B; Martel-Pelletier J; Uthman I; Khy V; Tremblay JL; Bertrand C; Pelletier JP
    Arthritis Rheum; 2003 Feb; 48(2):370-7. PubMed ID: 12571845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common antibiotic may stop OA's progression. Drug slows destruction of cartilage but fails to lessen pain.
    Health News; 2005 Nov; 11(11):11-2. PubMed ID: 16294432
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA.
    Roemer FW; Kwoh CK; Hayashi D; Felson DT; Guermazi A
    Nat Rev Rheumatol; 2018 Jun; 14(6):372-380. PubMed ID: 29752462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?
    Qvist P; Bay-Jensen AC; Christiansen C; Dam EB; Pastoureau P; Karsdal MA
    Pharmacol Res; 2008 Jul; 58(1):1-7. PubMed ID: 18590824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.